Literature DB >> 26920150

The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the "Hôpital Tenon" score revisited. A two-institution study.

I Barco1, A García-Fernández2, C Chabrera3, M Fraile4, E Vallejo1, J M Lain5, J Deu1, S González6, C González7, E Veloso8, J Torres9, M Torras1, L Cirera6, A Pessarrodona1, N Giménez10,11, M García-Font12.   

Abstract

INTRODUCTION: Until recently, completion ALND has been considered the standard of care after a positive SN in breast cancer patients. However, most patients will not display further axillary involvement. The Tenon score is a simple nomogram that can be used intraoperatively to avoid completion ALND in low-risk patients. We aimed at validating the Tenon score on a SN-positive patient sample that had been preoperatively selected using axillary US examination. PATIENTS AND
METHOD: We used a retrospective analysis of our bicentric database that included 246 breast cancer patients with a positive SN. We calculated sensitivity, specificity, as well as positive and negative predictive values for each cut-off point. ROCs were constructed and corresponding AUC values were calculated as a measure of discriminative capacity.
RESULTS: At least one non-SN was positive in 52 patients (21.1 %). 118 patients (48 %) had a score up to 5. Among them, three had at least one positive non-SN. NPV was 97.5 %. Using that threshold, the ROCs analysis showed an AUC of 0.822 (95 % CI 0.764-0.880).
CONCLUSION: Use of preoperative axillary US examination led to a modification of the proposed Tenon cut-off value from 3.5 to 5 to attain good predictive power for non-SN status. Straightforward intraoperative use of the Tenon score may be considered an advantage over other available nomograms.

Entities:  

Keywords:  Breast neoplasms; Non-sentinel lymph node metastasis; Prognosis; Scoring system; Sentinel lymph node biopsy

Mesh:

Year:  2016        PMID: 26920150     DOI: 10.1007/s12094-016-1487-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis.

Authors:  Liling Zhu; Liang Jin; Shunrong Li; Kai Chen; Weijuan Jia; Quanyuan Shan; Stephen Walter; Erwei Song; Fengxi Su
Journal:  Breast Cancer Res Treat       Date:  2013-01-05       Impact factor: 4.872

2.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

4.  Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram.

Authors:  Amy C Degnim; Carol Reynolds; Gouri Pantvaidya; Shaheen Zakaria; Tanya Hoskin; Sunni Barnes; Margaret V Roberts; Peter C Lucas; Kevin Oh; Meryem Koker; Michael S Sabel; Lisa A Newman
Journal:  Am J Surg       Date:  2005-10       Impact factor: 2.565

5.  Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.

Authors:  C Nos; C Harding-MacKean; P Fréneaux; A Trie; M C Falcou; X Sastre-Garau; K B Clough
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

6.  Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.

Authors:  Charles Coutant; Roman Rouzier; Eric Fondrinier; Frederic Marchal; François Guillemin; Nathalie Seince; Anabella Rodrigues; Emile Darai; Serge Uzan; Emmanuel Barranger
Journal:  Breast Cancer Res Treat       Date:  2008-03-14       Impact factor: 4.872

7.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Authors:  Anthony Lucci; Linda Mackie McCall; Peter D Beitsch; Patrick W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukumal Saha; Kelly K Hunt; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

8.  An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.

Authors:  R M Nadeem; L D Gudur; Z A Saidan
Journal:  Clin Breast Cancer       Date:  2014-03-02       Impact factor: 3.225

9.  Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012.

Authors:  Antonio García Fernández; Carol Chabrera; Marc García Font; Manel Fraile; Sonia Gónzalez; Israel Barco; Clarisa González; Lluís Cirera; Enrique Veloso; José María Lain; Antoni Pessarrodona; Nuria Giménez
Journal:  Tumour Biol       Date:  2013-04-19

10.  Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score.

Authors:  Y Andersson; J Frisell; J de Boniface; L Bergkvist
Journal:  Breast Cancer (Auckl)       Date:  2012-01-30
View more
  1 in total

1.  A logistic regression model predicting high axillary tumour burden in early breast cancer patients.

Authors:  I Barco; M García Font; A García-Fernández; N Giménez; M Fraile; J M Lain; E Vallejo; S González; L Canales; J Deu; M C Vidal; M Rodríguez-Carballeira; A Pessarrodona; C Chabrera
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.